Diagnosis and management options in malignant pleural effusions
暂无分享,去创建一个
Piyush Arora | Ramakant Dixit | KC Agarwal | Archana Gokhroo | Chetan B Patil | Manoj Meena | Narender S Shah | P. Arora | R. Dixit | K. Agarwal | Archana Gokhroo | C. B. Patil | M. Meena | N. S. Shah | C. Patil
[1] P. Rubin,et al. The management of pleural effusions and chylothorax in lymphoma. , 1965, Radiology.
[2] O. Järvi,et al. The accuracy and significance of cytologic cancer diagnosis of pleural effusions. (A followup study of 338 patients). , 1972, Acta cytologica.
[3] T B Ferguson,et al. The treatment of malignant pleural effusions , 1974, Cancer.
[4] C. Flower,et al. Ultrasound in the diagnosis and management of pleural disease. , 1980, British journal of diseases of the chest.
[5] M. Estenne,et al. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. , 1983, The American journal of medicine.
[6] A. Cantó,et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. , 1983, Chest.
[7] F. Rodríguez‐Panadero,et al. Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. , 1989, The American review of respiratory disease.
[8] C. Henschke,et al. MR imaging of pleural effusions. , 1990, Journal of computer assisted tomography.
[9] M. Tattersall,et al. Management of malignant pleural effusions. , 1990, Thorax.
[10] C. Bennett,et al. Treating malignant pleural effusions cost consciously. , 1998, Chest.
[11] C. Bedrossian. Diagnostic problems in serous effusions , 1998, Diagnostic cytopathology.
[12] J. Herndon,et al. Cytologically proved malignant pleural effusions: distribution of transudates and exudates. , 1998, Chest.
[13] A. Musk,et al. Management of malignant pleural mesothelioma: a critical review , 2000, Current opinion in pulmonary medicine.
[14] F. Gleeson,et al. Thoracic computed tomography in patients with suspected malignant pleural effusions. , 2001, Clinical radiology.
[15] R. Davies,et al. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial , 2003, The Lancet.
[16] Chin-Pyng Wu,et al. Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies. , 2004, Chest.
[17] R. Louis,et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. , 2004, Chest.
[18] J. M. Porcel,et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.
[19] S. Sahn,et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. , 2004, Chest.
[20] R. Dixit,et al. Intrapleural streptokinase in multiloculated malignant pleural effusion. , 2004, The Indian journal of chest diseases & allied sciences.
[21] Fergus V Gleeson,et al. Radiology in pleural disease: State of the art , 2004, Respirology.
[22] S. Mercadante,et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. , 2005, Journal of pain and symptom management.
[23] F. Gleeson,et al. Imaging of pleural disease. , 2006, Clinics in chest medicine.
[24] A. Tremblay,et al. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. , 2005, Chest.
[25] N. Ordóñez. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. , 2007, Human pathology.
[26] M. Noppen,et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study , 2007, The Lancet.
[27] J. M. Porcel,et al. Prognostic significance of pleural fluid data in patients with malignant effusion. , 2008, European journal of internal medicine.
[28] F. Gleeson,et al. Thoracic ultrasound in the diagnosis of malignant pleural effusion , 2008, Thorax.
[29] J. Heffner,et al. Recent advances in the diagnosis and management of malignant pleural effusions. , 2008, Mayo Clinic proceedings.
[30] W. Su,et al. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. , 2009, Lung cancer.
[31] M. Narasimhan,et al. Pleural Ultrasonography , 2010 .
[32] M. Raza. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .
[33] E. Duhig,et al. Diagnostic molecular biomarkers for malignant pleural effusions. , 2011, Future oncology.
[34] R. Davies,et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.
[35] J. Kastelik,et al. Management of Malignant Pleural Effusion , 2013, Lung.
[36] H. Colt,et al. Pleuroscopy in 2013. , 2013, Clinics in chest medicine.
[37] D. Sterman,et al. Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. , 2013, Clinics in chest medicine.
[38] J. Porcel. Pleural fluid biomarkers: beyond the Light criteria. , 2013, Clinics in chest medicine.
[39] F. Gleeson,et al. Role of CT in assessing pleural malignancy prior to thoracoscopy , 2012, Thorax.
[40] A. Fernández-Villar,et al. Management of malignant pleural effusion by an indwelling pleural catheter: A cost-efficiency analysis , 2015, Annals of thoracic medicine.
[41] J. M. Porcel,et al. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. , 2015, Chest.